Johnson & Johnson Wins in Court
June 29, 2009 by Stephen Kersey
Filed under Business
Johnson & Johnson said that Abbott Laboratories infringed on their patented arthritis treatments. On Monday, a United States federal judge agreed. The verdict? A whopping $1.67 billion for Johnson & Johnson.
The money was awarded to Centocor Ortho Biotech Inc., which is a wholly-owned subsidiary of Johnson & Johnson.
Said Kim Taylor, Centocor Ortho Biotech Inc.’s President: “We are pleased that the jury has ruled in our favor in the patent litigation case against Abbott.
“We are particularly gratified that the jury recognized our valuable intellectual property, finding our patent both valid and infringed. We will continue to assert intellectual property rights for our immunology therapies, as they offer significant advances in treatment for patients with a number of immune mediated inflammatory diseases.”
The patent that Abbott Laboratories infringed upon was an anti-TNF class arthritis treatment.
Johnson & Johnson Logo (Image: Flickr)
